Uncategorized
Implant may offer safe alternative to MMC in glaucoma filtration surgery
WASHINGTON — The Ologen collagen matrix implant may offer a safer alternative to mitomycin C in glaucoma filtration surgery, studies and surgical experience are showing, according to a speaker here. At the American Glaucoma Society meeting, Steven R. Sarkisian, MD, discussed the results of several recent studies that show the comparative safety and efficacy of the Ologen implant (Aeon Astron) in trabeculectomy procedures against MMC. “Ologen offers an opportunity for wound modulation while avoiding the most dreaded late complications we see with MMC,” he said.